Shareholder Alert: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investments to Contact Them

Pomerantz LLP Investigating Claims Against AstraZeneca PLC New York, NY / ACCESS Newswire / January 26, 2025 Pomerantz LLP, a leading law firm specializing in securities litigation, is currently investigating claims on behalf of investors of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ:AZN). It has come to our attention that investors may have suffered losses…

Read More

URGENT: Don’t Miss Out on Your Chance for Justice – Deadline Approaching for GigaCloud Technology Inc. Investors in Securities Class Action Lawsuit, Advised by Top-Ranked Global Counsel Rosen

GCT IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GigaCloud Technology Inc. Investors with Losses to Sec… Introduction NEW YORK, Dec. 02, 2023 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of GigaCloud Technology Inc. (NASDAQ: GCT): (i) Class A ordinary shares pursuant and/or traceable to the registration statement…

Read More

Unleashing the Potential: BlockDAG’s Projected 30,000% ROI Surpasses Ethereum, ETF, and Cardano Forecasts, Resulting in a 0.001 Price Surge!

Welcome to the Cryptocurrency Rollercoaster Ride! The Rise of BlockDAG Network BlockDAG is quickly establishing itself as a powerhouse in the cryptocurrency world, with a projected 30,000% return on investment that significantly overshadows the prospects of Ethereum ETFs and Cardano price predictions. As it garners attention with a successful presale, raising over $17.3 million and…

Read More

Breaking News: RetinalGenix Technologies Inc. Submits Two Patent Applications for Exciting New Therapeutic Drugs!

RetinalGeniX™ Technologies Inc. Announces the Submission of Provisional Patent Applications for Therapeutic Solutions for Dry Age-Related Macular Degeneration and Alzheimer’s Syndrome PETALUMA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) — Exciting news in the field of medical research as RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) unveils their latest advancements in therapeutic drug candidates RTG-2023 and RTG-2024. RTG-2023 and…

Read More

Breaking News: ERES REIT Announces Monthly Distribution for August 2024!

European Residential REIT Declares August Cash Distribution TORONTO, Aug. 15, 2024 GLOBE NEWSWIRE European Residential Real Estate Investment Trust (TSX: ERE.UN, “ERES”) has announced the declaration of the August 2024 monthly cash distribution of €0.01 per Unit and Class B LP Unit (the “August Distribution”), equivalent to €0.12 per Unit annualized. The distribution will be…

Read More

“Unveiling the Future of Healthpeak Properties Inc: A Recap of the Q4 2024 Earnings Call”

Welcome to Healthpeak Properties, Inc.’s Q4 2024 Earnings Conference Call Key Participants: – Andrew Johns – Senior Vice President, IR – Scott Brinker – President and CEO – Peter Scott – Chief Financial Officer – Scott Bohn – Chief Development Officer & Head of Lab – Tom Klaritch – Chief Operating Officer Conference Call Participants:…

Read More

Act Now: Important Deadline Approaching for Edwards Lifesciences Corporation Investors – A Reminder from Kessler Topaz Meltzer & Check LLP

Investor Alert: Securities Class Action Lawsuit Filed Against Edwards Lifesciences Corporation Overview The law firm of Kessler Topaz Meltzer & Check, LLP has announced that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation on behalf of investors who purchased or acquired Edwards securities during the Class Period. The lead plaintiff deadline…

Read More